This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
C3_BILIARY_TRACT_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
679 |
4. Check minimum number of eventsNone |
679 |
5. Include endpointsNone |
679 |
6. Filter based on genotype QC (FinnGen only) |
679 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 679 | 285 | 394 |
| Unadjusted period prevalence (%) | 0.14 | 0.10 | 0.17 |
| Median age at first event (years) | 71.06 | 70.66 | 71.35 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 394
- Matched controls
- 3939
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
298.2
247
*
A03FA01
ATC
metoclopramide; systemic, rectal
26.6
148.7
225
187
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
146.2
131
*
K83.1
ICD-10 Finland
Obstruction of bile duct
201.9
135.2
134
10
H02AB02
ATC
dexamethasone; systemic
148.9
134.5
137
14
A04AA02
ATC
granisetron; systemic, transdermal
+∞
129.5
117
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
120.1
109
*
Z51.5
ICD-10 Finland
Palliative care
61.0
118.4
137
34
UJK02
NOMESCO Finland
ERCP
62.0
115.3
133
32
JLC30
NOMESCO Finland
Pancreatoduodenectomy
697.3
110.5
104
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
697.3
110.5
104
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
89.0
109.4
119
19
L01BC06
ATC
capecitabine; oral
+∞
102.7
94
*
N02AA05
ATC
oxycodone; systemic
13.4
96.6
194
266
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
98.9
95.8
103
14
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
94.7
87
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
85.6
79
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
80.6
84.1
93
15
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
81.1
75
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
81.1
75
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
77.7
72
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
60.1
76.7
89
19
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
125.0
76.2
80
8
WX302
NOMESCO Finland
Thoracal epidural anesthesy
33.4
72.1
95
37
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
46.1
71.3
87
24
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
801.1
70.3
67
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
69.9
65
*
JN4BD
NOMESCO Finland
Extensive body CT
17.8
68.6
112
86
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
64.3
60
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
51.8
63.8
76
18
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
58.8
55
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
56.6
53
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
304.9
53.5
53
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
53.3
50
*
K83.0
ICD-10 Finland
Cholangitis
42.9
52.6
65
18
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
48.7
51.5
62
15
C24.02
ICD-10 Finland
Common bile duct
+∞
51.2
48
*
JN4CD
NOMESCO Finland
Very extensive body CT
26.0
50.6
71
33
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
36.1
49.9
64
21
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
49.0
46
*
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
49.0
46
*
A04AA01
ATC
ondansetron; systemic, rectal
23.9
43.9
63
31
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
10.1
43.0
91
114
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.1
42.2
168
502
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
42.5
42.1
52
14
JN4AD
NOMESCO Finland
Body CT examination
13.6
41.9
75
67
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
41.4
39
*
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
41.4
39
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.4
39.2
68
56
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
38.1
36
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.8
37.2
68
63
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
37.1
35
*
WZC30
NOMESCO Finland
Teaching
7.6
36.4
92
152
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.5
34.9
100
196
R50.9
ICD-10 Finland
Fever, unspecified
5.5
34.7
117
281
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
33.5
143
439
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
32.8
31
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
350.5
32.3
32
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
29.9
32.2
43
16
A04AA55
ATC
palonosetron, combinations; systemic
+∞
31.7
30
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.4
31.2
104
243
JAH01
NOMESCO Finland
Laparoscopy
13.4
31.0
55
47
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
30.6
29
*
B01AB10
ATC
tinzaparin; parenteral
11.5
30.4
58
58
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.3
30.1
65
82
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
29.6
101
241
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
29.5
28
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
28.5
27
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
28.5
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
301.6
28.1
28
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
155.9
28.0
29
*
B01AB05
ATC
enoxaparin; parenteral
3.6
27.6
166
665
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
27.4
26
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
11.3
26.7
51
51
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
26.3
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
6.7
25.0
67
117
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
24.2
23
*
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
24.2
23
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
24.2
23
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
23.1
22
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
20.5
23.0
34
18
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
127.3
22.8
24
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
29.3
22.6
30
11
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
22.1
21
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
22.1
21
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.1
21.9
74
171
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
121.7
21.8
23
*
R4190
NOMESCO Finland
Nutritional therapy
14.5
21.4
36
27
A06AH03
ATC
naloxegol; oral
63.6
21.1
24
*
A04AD12
ATC
aprepitant; systemic
+∞
21.0
20
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.8
20.7
45
57
WX402
NOMESCO Finland
General anaesthesia
4.3
20.1
80
218
XX3DW
NOMESCO Finland
Time consuming IT work
6.9
19.9
51
83
L03AA02
ATC
filgrastim; parenteral
210.0
19.7
20
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
19.0
123
494
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.2
19.0
33
27
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
18.9
18
*
J01MA12
ATC
levofloxacin; systemic
3.2
18.6
115
447
WW500
NOMESCO Finland
Blood transfusion
13.3
17.9
31
25
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
38.7
17.8
22
6
D77
ICPC
Malignant digestive neopl other/NOS
+∞
16.8
16
*
A02BC02
ATC
pantoprazole; systemic
2.5
16.3
273
1860
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
166.2
15.6
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
15.2
84
298
JAH00
NOMESCO Finland
Laparotomy
8.8
15.1
32
39
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
14.7
14
*
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
155.4
14.6
15
*
R18
ICD-10 Finland
Ascites
14.3
13.9
23
17
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
13.6
83
312
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
13.6
13
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
13.6
13
*
C24.01
ICD-10 Finland
Cystic duct
+∞
13.6
13
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.6
13
*
A06AD11
ATC
lactulose; oral
2.7
13.3
101
439
A05AA02
ATC
ursodeoxycholic acid; oral
16.1
12.7
20
13
UJK12
NOMESCO Finland
Peroral cholangioscopy
72.2
12.7
14
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.6
12
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
12.6
12
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
11.5
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
123.4
11.5
12
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
123.4
11.5
12
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
11.3
89
389
ZX120
NOMESCO Finland
Intravenous
3.7
11.0
49
146
WX004
NOMESCO Finland
Patient-controlled sedation
28.9
10.8
14
5
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
10.5
10
*
D76
ICPC
Malignant neoplasm pancreas
+∞
10.5
10
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
33.5
10.4
13
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
33.5
10.4
13
*
JKA20
NOMESCO Finland
Cholecystectomy
5.9
10.3
28
50
WX892
NOMESCO Finland
Monitored bed care
3.7
10.3
45
132
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.1
9.8
23
34
WX002
NOMESCO Finland
Sedation and analgesia
2.4
9.4
86
408
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
91.9
8.4
9
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
13.1
8.4
14
11
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
8.8
8.4
17
20
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
K75.0
ICD-10 Finland
Abscess of liver
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
8.4
8
*
R4110
NOMESCO Finland
Physiotherapy
2.1
8.3
102
552
A98
ICPC
Health maint/preventive medicine
0.5
8.2
241
2960
WF002
NOMESCO Finland
Radical radiotherapy
34.1
8.1
10
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
34.1
8.1
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
22.5
8.1
11
5
WX704
NOMESCO Finland
Intubation
3.7
8.0
34
98
WX725
NOMESCO Finland
Noninvasive ventilation
4.5
8.0
27
63
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.8
8.0
19
29
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
4.8
7.8
25
55
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
7.8
27
65
K85.8
ICD-10 Finland
Other acute pancreatitis
15.4
7.8
12
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
7.5
175
1197
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.2
7.4
27
68
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
13.7
7.4
12
9
JK3MB
NOMESCO Finland
Postoperative cholangiography
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
Y77
ICPC
Malignant neoplasm prostate
+∞
7.3
7
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
16.1
7.3
11
7
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.3
163
1100
A41.8
ICD-10 Finland
Other specified sepsis
7.2
7.1
16
23
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
6.7
23
55
K76.9
ICD-10 Finland
Liver disease, unspecified
7.6
6.5
14
19
ZX090
NOMESCO Finland
Other technic of radiotherapy
70.9
6.4
7
*
WX882
NOMESCO Finland
High dependency care
5.7
6.4
17
31
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.3
6.3
11
10
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
9.5
6.3
12
13
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
8163/3-C24.1
ICD-O-3
Pancreatobiliary type carcinoma of ampulla of Vater
+∞
6.3
6
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
6.3
6
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
6.3
6
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
6.3
6
*
D13
ICPC
Jaundice
+∞
6.3
6
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
6.3
6
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
6.1
165
1159
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.8
6.1
10
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.1
117
741
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
420
276
38.27
307.65
7.3
1.3
35.1
3.9
ug/l
1.69
393
206
264
99
42.99
307.65
6.7
1.7
3109.1
82.0
u/ml
0.81
249
77
148
16
118.00
289.64
1.5
1.1
—
—
—
0
0
264
389
10.47
185.30
5.5
1.8
0.2
0.2
g/l
4.44
252
346
263
504
7.89
143.38
9.1
2.2
49.5
8.2
umol/l
12.10
245
441
128
122
12.70
120.84
1.7
1.3
126.2
306.1
ug/g
12.61
81
72
420
1557
5.45
105.35
9.1
2.2
56.2
57.2
u/l
0.11
406
1426
250
735
4.80
80.00
4.9
2.6
0.8
0.8
mmol/l
6.70
241
667
454
2184
4.26
71.67
14.5
3.5
30.4
35.2
g/l
44.85
439
1995
483
2438
4.40
70.88
30.8
3.6
32.2
12.3
umol/l
9.52
477
2270
160
403
4.89
60.54
9.6
2.1
48.0
36.2
u/l
0.62
155
324
333
1416
3.65
60.37
10.1
2.6
65.4
34.3
u/l
11.60
321
1339
159
438
4.43
53.25
6.7
5.9
7.7
10.9
mmol/l
5.38
151
410
385
2124
2.88
39.80
7.1
3.5
—
—
—
0
0
70
123
6.23
38.94
3.0
2.3
34.3
35.8
umol/l
0.18
58
105
28
13
22.42
37.63
2.0
1.1
27.3
28.9
umol/l
0.23
28
13
246
1097
2.95
37.54
4.0
2.0
—
—
—
0
0
115
321
4.11
37.08
1.6
1.5
—
—
—
0
0
431
2623
2.76
35.21
24.5
6.0
4.4
4.3
e9/l
0.22
400
2273
199
860
2.86
31.38
2.1
1.8
—
—
—
0
0
85
220
4.27
30.11
2.2
1.7
4.0
1.6
ug/l
0.60
80
187
303
1670
2.47
28.59
8.0
2.1
2.3
2.4
mmol/l
3.15
286
1362
406
2578
2.43
27.56
9.2
5.4
1.2
1.2
mmol/l
6.13
335
2175
377
2352
2.36
26.15
8.0
5.1
1.2
1.2
mmol/l
6.73
360
2075
159
668
2.80
25.93
4.3
4.5
1.0
1.0
mmol/l
0.02
152
597
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
156
4.35
23.53
3.0
2.7
0.3
0.4
u/ml
2.03
34
88
96
324
3.29
22.88
1.7
1.4
—
—
—
0
0
55
125
4.70
22.86
1.8
1.6
—
—
—
0
0
444
3078
2.28
22.57
9.9
4.2
7.4
6.9
mmol/l
4.84
432
2878
200
1028
2.34
20.85
9.8
2.3
2.5
2.4
mmol/l
6.59
190
872
168
802
2.45
20.67
2.5
2.3
10.5
13.1
umol/l
4.85
163
724
123
516
2.69
19.72
10.1
7.0
117.3
121.4
g/l
1.31
117
502
146
668
2.51
19.59
2.4
2.4
19.9
23.7
%
2.41
137
559
422
2961
2.12
19.50
9.5
2.9
272.4
49.5
u/l
27.07
398
2688
135
616
2.49
18.11
2.0
1.8
—
—
—
0
0
134
617
2.46
17.59
1.9
1.8
—
—
—
0
0
148
714
2.37
17.51
2.4
2.3
2.2
2.3
g/l
0.40
140
651
496
3807
2.12
16.71
32.7
5.1
201.6
76.6
u/l
33.90
489
3480
134
638
2.37
16.24
9.7
6.3
0.3
1.5
mmol/l
3.44
112
485
134
643
2.35
15.94
9.7
6.3
5.0
5.1
kpa
0.80
127
614
134
643
2.35
15.94
9.7
6.3
14.2
11.4
kpa
7.09
125
613
329
2217
1.94
15.77
5.4
5.5
20.9
26.7
%
15.11
312
2035
24
36
6.87
15.39
1.9
1.1
—
—
—
0
0
248
1544
1.96
14.81
3.5
3.1
63.3
109.5
e6/l
0.46
205
1196
94
404
2.54
14.14
4.9
2.7
1.2
1.2
mmol/l
2.70
88
346
278
1852
1.85
13.12
3.7
3.0
—
—
—
0
0
17
9
19.33
11.63
3.9
1.0
94.6
90.2
%
—
17
9
29
68
4.41
11.58
4.2
6.3
589.4
110.9
iu/ml
—
7
7
16
21
7.78
11.46
1.1
1.0
—
—
—
0
0
109
547
2.18
11.43
4.7
3.0
—
—
—
0
0
431
5123
0.57
10.88
4.3
5.5
2.6
2.6
mmol/l
0.65
363
4629
179
1092
1.87
10.81
2.9
2.3
7.0
5.0
e6/l
1.21
161
946
60
236
2.69
10.75
7.2
4.4
1.7
1.6
%
0.62
55
228
217
1411
1.79
10.62
3.6
3.0
0.7
0.4
e6/l
0.75
175
1071
423
3314
1.73
10.57
5.4
4.5
2.9
3230.5
e6/l
—
7
57
68
1411
0.42
10.57
1.9
1.6
1.4
1.3
mmol/l
0.07
58
1162
37
117
3.29
9.73
2.1
2.1
81.0
88.8
%
0.86
37
111
21
44
4.89
9.59
1.3
1.1
—
—
—
0
0
53
210
2.65
9.37
2.2
1.6
—
—
—
0
0
423
4996
0.59
9.35
4.1
4.9
4.4
4.5
mmol/l
1.32
360
4533
417
4942
0.60
9.33
4.1
4.8
1.3
1.4
mmol/l
4.73
347
4452
27
71
3.92
9.31
1.1
1.1
—
—
—
0
0
428
5029
0.60
9.06
4.6
5.0
6.3
6.1
mmol/l
1.37
370
4498
381
4598
0.61
8.90
4.4
4.6
2.3
2.3
mu/l
0.01
325
4103
20
43
4.76
8.87
1.4
1.1
—
—
—
0
0
20
43
4.76
8.87
1.4
1.1
—
—
—
0
0
20
44
4.65
8.64
1.4
1.1
—
—
—
0
0
20
44
4.65
8.64
1.4
1.1
—
—
—
0
0
19
42
4.63
8.16
1.4
1.1
—
—
—
0
0
48
196
2.56
8.00
2.1
1.5
—
—
—
0
0
31
100
3.20
7.92
2.1
2.6
15.1
16.6
%
—
10
47
29
90
3.32
7.88
1.7
1.4
—
—
—
0
0
30
97
3.19
7.64
1.6
1.4
—
—
—
0
0
75
380
2.09
7.61
8.0
7.3
23.9
24.6
mmol/l
0.81
69
358
93
515
1.93
7.37
3.1
3.2
1.4
2.1
mmol/l
0.82
75
414
417
4851
0.64
7.23
7.5
6.6
41.9
40.9
mmol/mol
1.25
375
4435
20
52
3.93
7.02
1.2
2.3
—
281.2
—
0
6
23
67
3.52
6.89
1.3
1.2
—
—
—
0
0
22
63
3.58
6.76
2.0
2.0
92.1
89.9
%
1.77
22
63
23
69
3.42
6.60
1.1
1.1
343.1
269.7
u/ml
0.31
17
36
412
4771
0.65
6.53
3.9
4.3
1.3
1.3
mmol/l
0.04
349
4255
22
66
3.41
6.32
1.5
1.4
—
—
—
0
0
26
87
3.07
6.29
1.3
1.2
—
—
—
0
0
125
800
1.69
6.10
3.2
2.9
3.3
2.5
e6/l
0.25
72
436
19
53
3.66
6.07
2.8
2.1
—
—
—
0
0
64
335
2.01
5.96
1.8
1.6
—
—
—
0
0
15
36
4.24
5.85
1.3
1.5
—
—
—
0
0
79
450
1.86
5.74
1.6
1.7
1.6
1.6
%
0.02
64
374
27
99
2.80
5.59
1.1
1.3
—
—
—
0
0
20
62
3.29
5.48
1.6
1.3
—
—
—
0
0
310
3731
0.69
5.36
3.9
3.7
15.2
15.0
pmol/l
0.49
258
3320
19
58
3.34
5.34
1.6
1.3
—
—
—
0
0
125
834
1.61
5.15
16.9
27.2
1.4
1.4
inr
0.18
21
109
23
82
2.87
5.02
3.6
2.9
62.5
60.5
%
0.22
23
82
182
1335
1.50
4.89
2.5
2.2
3.4
3.0
mg/l
0.61
161
1109
54
288
1.95
4.80
2.3
2.5
1.6
0.2
e6/l
1.34
54
278
26
102
2.61
4.77
1.7
1.6
—
—
—
0
0
13
33
4.00
4.73
1.5
1.5
—
—
—
0
0
15
43
3.54
4.63
1.5
1.6
—
—
—
0
0
18
59
3.11
4.54
1.6
1.4
—
—
—
0
0
20
71
2.87
4.42
1.6
1.4
—
—
—
0
0
132
1795
0.67
4.06
3.9
3.8
20.5
24.4
%
3.00
64
878
508
5510
0.69
4.06
63.1
20.2
119.0
135.6
g/l
87.07
500
5385
508
5510
0.69
4.06
62.7
20.1
4.0
4.5
e12/l
60.00
495
5301
151
1112
1.46
3.89
3.9
4.1
580.3
369.9
ng/l
0.18
124
944
43
230
1.93
3.83
4.0
4.1
1.6
1.5
mmol/l
0.21
43
225
16
55
2.96
3.76
1.3
1.3
—
—
—
0
0
174
2224
0.71
3.75
4.1
4.0
1.9
2.1
ug/l
0.70
143
1971
20
80
2.55
3.57
2.8
2.6
5.3
4.8
e9/l
0.16
20
80
7
9
7.84
3.56
1.0
1.1
—
—
—
0
0
86
1243
0.65
3.52
2.7
2.7
0.6
0.8
ug/l
2.76
57
861
272
2249
1.35
3.50
4.2
4.0
24.0
79.5
ng/l
1.87
227
1692
48
794
0.57
3.45
1.3
1.3
55.7
40.8
iu/ml
0.22
15
243
29
140
2.12
3.42
1.1
1.1
—
—
—
0
0
120
866
1.47
3.42
3.0
2.7
1.7
1.3
e6/l
0.38
66
502
8
14
5.77
3.35
1.9
1.9
—
—
—
0
0
132
1736
0.70
3.28
1.9
2.2
152.2
271.5
u/l
1.58
120
1613
9
20
4.55
3.12
1.3
1.6
—
—
—
0
0
9
20
4.55
3.12
1.3
1.6
—
—
—
0
0
9
23
3.95
2.78
1.3
1.5
—
—
—
0
0
46
284
1.66
2.62
1.8
2.4
1.1
1.1
%
0.25
46
284
17
74
2.33
2.60
1.2
1.4
—
—
—
0
0
11
38
2.93
2.59
1.1
1.0
—
—
—
0
0
49
312
1.61
2.49
3.2
3.8
2.0
2.0
mmol/l
0.02
33
231
9
27
3.36
2.40
1.0
1.3
—
—
—
0
0
12
277
0.42
2.39
1.4
1.8
—
—
—
0
0
52
769
0.65
2.36
1.3
1.3
1.4
13.4
u/ml
5.18
18
295
44
278
1.62
2.32
1.9
2.4
0.7
0.7
%
0.38
44
267
11
41
2.71
2.28
1.4
1.3
—
—
—
0
0
6
13
4.65
2.27
1.0
2.0
—
—
—
0
0
11
42
2.65
2.19
1.2
1.2
28098.3
182303.9
e6/l
—
6
27
29
166
1.78
2.18
2.2
3.2
—
—
—
0
0
224
1904
1.26
2.13
4.2
3.9
—
—
—
0
0
435
4694
0.80
2.12
43.1
12.7
79.9
74.1
ml/min/173m2
7.64
387
3790
33
199
1.69
2.09
3.7
2.9
4.2
4.5
pmol/l
0.75
28
169
22
117
1.91
2.08
1.6
2.3
117.1
133.7
g/l
1.95
16
84
7
20
3.53
2.06
1.9
1.4
—
—
—
0
0
11
44
2.52
2.02
1.4
1.3
—
—
—
0
0
8
26
3.10
2.02
1.3
1.2
—
—
—
0
0
166
1372
1.28
1.98
4.7
3.9
0.0
0.0
estimate
0.00
62
409
503
5324
0.79
1.97
35.6
9.1
43.1
25.3
u/l
25.01
495
5066
22
120
1.86
1.95
1.6
1.3
—
—
—
0
0
22
120
1.86
1.95
1.6
1.4
—
—
—
0
0
228
1960
1.25
1.94
2.8
2.7
209.4
139.2
ug/l
2.89
215
1757
506
5342
0.79
1.85
49.3
17.0
3.9
4.0
mmol/l
6.21
498
5173
154
1836
0.79
1.79
2.9
3.1
7.5
7.4
mmol/l
0.05
113
1525
234
2039
1.23
1.73
2.6
2.2
69.7
78.7
nmol/l
5.06
218
1750
506
5330
0.80
1.72
49.3
16.9
137.7
139.7
mmol/l
37.43
498
5166
162
1903
0.80
1.63
3.9
3.9
8.0
7.9
mg/mmol
0.02
94
1197
12
56
2.16
1.62
3.3
2.5
622.9
634.3
ml
—
7
41
36
240
1.53
1.58
1.6
1.5
1.5
1.6
g/l
0.22
30
201
14
72
1.96
1.49
2.1
1.4
—
—
—
0
0
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
277
2490
1.19
1.43
4.1
3.8
0.0
0.0
estimate
0.00
69
418
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
272
2459
1.18
1.28
4.1
3.7
0.0
0.0
estimate
0.00
70
423
55
422
1.33
1.18
2.2
1.8
412.5
359.3
nmol/l
0.97
50
384
72
574
1.28
1.17
2.0
2.5
3.9
6.9
ug/l
1.94
66
498
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
270
2457
1.16
1.15
5.1
5.1
0.0
0.0
estimate
0.00
70
418
7
30
2.35
1.12
2.9
2.5
—
—
—
0
0
19
288
0.65
1.05
1.1
1.4
—
45.7
—
0
12
11
61
1.82
0.99
1.0
1.4
—
—
—
0
0
11
187
0.58
0.99
1.6
1.7
—
—
—
0
0
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
6
28
2.15
0.91
2.2
1.3
0.9
1.0
g/l
—
6
28
205
1858
1.15
0.90
3.5
3.0
1569.2
1766.7
ng/l
0.20
178
1578
116
1006
1.18
0.89
2.8
1.7
3.2
1.3
mg/l
2.04
102
784
7
129
0.54
0.88
1.0
1.2
—
21.9
—
0
7
61
742
0.80
0.87
16.0
7.6
—
—
—
0
0
8
46
1.75
0.82
1.0
1.3
—
—
—
0
0
8
47
1.71
0.81
1.0
1.1
—
—
—
0
0
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
0
25
0.00
0.79
0.0
2.2
—
1370.3
—
0
25
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
5
97
0.51
0.78
1.0
1.2
—
37.0
—
0
9
7
124
0.56
0.78
1.0
1.2
—
4.6
—
0
19
124
1390
0.87
0.72
2.5
2.5
358.2
9258.9
umol/l
6.66
104
1163
58
688
0.83
0.68
4.0
5.1
33.0
32.3
%
0.16
34
428
8
131
0.61
0.64
1.1
1.3
414.6
525.6
mg/l
—
8
121
6
103
0.58
0.62
1.0
1.2
—
2.7
—
0
7
129
1426
0.88
0.62
1.8
1.6
20.6
20.7
nmol/l
0.05
123
1194
13
88
1.49
0.61
1.0
1.3
—
—
—
0
0
7
112
0.62
0.58
1.1
1.2
4.6
3.9
mmol/l
—
7
103
10
146
0.68
0.52
1.1
2.0
—
—
—
0
0
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
17
128
1.34
0.48
1.5
1.4
—
—
—
0
0
16
120
1.34
0.46
1.9
1.5
—
—
—
0
0
12
164
0.73
0.45
1.5
1.6
—
—
—
0
0
229
2410
0.92
0.42
2.8
2.3
—
—
—
0
0
21
167
1.27
0.42
3.5
2.4
85.0
90.2
ug/min
0.05
11
105
18
228
0.78
0.42
1.1
1.2
467.3
111.3
iu/ml
—
6
87
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
48
420
1.15
0.39
4.2
2.4
69.1
60.5
ml/min/173m2
0.95
24
170
17
133
1.29
0.39
1.8
1.6
16058.4
15488.9
e6/l
0.02
11
92
11
80
1.38
0.38
3.0
2.2
4.0
4.1
mmol/l
0.55
11
80
11
80
1.38
0.38
3.0
2.2
106.1
105.2
mmol/l
0.27
11
80
38
439
0.86
0.37
1.4
1.4
—
—
—
0
0
14
180
0.77
0.37
1.1
1.1
—
—
—
0
0
11
141
0.78
0.29
1.1
1.2
—
—
—
0
0
11
141
0.78
0.29
1.1
1.2
—
—
—
0
0
231
2394
0.95
0.26
2.2
2.1
92.4
93.2
pmol/l
0.09
136
1214
5
74
0.67
0.26
1.0
1.5
42.6
68.0
%
—
5
45
11
87
1.27
0.24
1.1
1.3
—
—
—
0
0
87
926
0.93
0.23
1.2
1.2
5.0
1.7
u/ml
0.55
21
261
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
21
182
1.16
0.21
1.5
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
14.4
—
0
9
501
4947
1.05
0.20
47.4
13.7
42.0
24.6
mg/l
20.72
492
3889
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
48
518
0.92
0.18
1.3
1.3
—
—
—
0
0
371
3776
0.96
0.18
4.6
4.1
22.0
12.9
mm/h
12.10
334
3417
7
59
1.19
0.18
4.3
3.7
—
—
—
0
0
122
1174
1.05
0.16
4.6
4.1
1.0
1.0
kg/l
0.07
24
181
6
76
0.79
0.15
1.2
1.2
0.5
0.6
nmol/l
—
6
68
9
78
1.16
0.15
1.2
1.1
—
—
—
0
0
118
1215
0.97
0.11
2.0
1.8
1275.6
1190.1
nmol/l
0.43
99
904
41
433
0.94
0.10
2.4
3.6
58.8
89.3
ng/l
4.65
41
373
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
5
62
0.81
0.08
1.8
1.4
—
—
—
0
0
5
63
0.79
0.08
1.4
1.1
—
—
—
0
0
430
4333
0.98
0.08
39.3
15.1
34.3
39.5
%
13.52
257
2712
6
75
0.80
0.07
1.2
1.2
—
0.7
nmol/l
—
0
6
8
93
0.86
0.06
1.5
1.3
—
—
—
0
0
15
157
0.95
0.01
1.3
1.4
—
—
—
0
0
21
217
0.97
0.01
1.2
1.3
—
—
—
0
0
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
12
121
0.99
0.00
1.9
1.7
—
—
—
0
0
128
1278
1.00
0.00
1.7
1.7
151402366.2
18324020.4
pmol/l
0.42
107
1026
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
0.6
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
16.9
—
0
5
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
102.6
—
0
5
5
51
0.98
0.00
1.6
2.5
—
1.6
—
0
17
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
76.0
—
0
8
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
24.4
—
0
6
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_TRACT_EXALLC – Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).